There is encouraging news on the development of vaccines to beat the coronavirus.
No fewer than four vaccine candidates are in advanced clinical trials. Major pharmaceutical companies such as Astra Zeneca and Moderna are working round the clock to bring an effective vaccine to market.
However, the amazing work of thousands of researchers and scientists will appear easy compared to the difficulty in deploying effective vaccinations for over 300 million Americans. Given the early stumbles by the Centers for Disease Control (CDC) on testing and recurring issues with securing critical protective and test kit supplies, many will correctly question whether the federal and state governments are up to the task of vaccine distribution.
Read Full Article »